SAGE

SAGE Therapeutics Inc

Price:

11.80

USD

Volume:

737,025.00

United States | Biotechnology

-454.23 %

Upside

As of 2024-07-16, the Fair Value of SAGE Therapeutics Inc (SAGE) is -41.80 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.80 USD, the upside of SAGE Therapeutics Inc is -454.23%.

Note: valuation result may not be accurate due to the company's negative EPS.

11.80 USD

Stock Price

-41.80 USD

Fair Price

Peter Lynch's formula is:

SAGE Fair Value

= Earnings Growth Rate x TTM EPS
SAGE Fair Value

= 5.00 x -8.36
SAGE Fair Value

= -41.80
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -680.20 | 606.10 | -457.90 | -532.80 | -541.49 | -321.26 |

YoY growth | -82.41% | 189.11% | -175.55% | -16.36% | -1.63% | -17.37% |

Market Cap (mil) | 710.12 |

P/E | |

Forward P/E |

EPS | -8.36 |

Avg earnings growth rate | -17.37% |

TTM earnings | -503.09 |